Literature DB >> 18371311

Unconventional secretion of fibroblast growth factor 2 and galectin-1 does not require shedding of plasma membrane-derived vesicles.

Claudia Seelenmeyer1, Carolin Stegmayer, Walter Nickel.   

Abstract

Various molecular mechanisms of unconventional secretion of fibroblast growth factor 2 and galectin-1 have been proposed. A non-vesicular pathway that is based on direct translocation across the plasma membrane has been described. In other studies, however, release into the extracellular space of cell-derived vesicles was implicated in both FGF-2 and Gal-1 secretion. Such vesicles were proposed to originate either from plasma membrane shedding or by the release of exosomes. Employing an inhibitor of plasma membrane blebbing and based on a quantitative biochemical analysis of cell culture supernatants for vesicles potentially carrying FGF-2 or Gal-1, we demonstrate that both FGF-2 and Gal-1 are not exported by shedding of plasma membrane-derived vesicles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18371311     DOI: 10.1016/j.febslet.2008.03.024

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

Review 1.  Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

Authors:  Anthony R Mele; Jamie Marino; Kenneth Chen; Vanessa Pirrone; Chris Janetopoulos; Brian Wigdahl; Zachary Klase; Michael R Nonnemacher
Journal:  Traffic       Date:  2018-04-30       Impact factor: 6.215

Review 2.  The bisecting GlcNAc in cell growth control and tumor progression.

Authors:  Hazuki E Miwa; Yinghui Song; Richard Alvarez; Richard D Cummings; Pamela Stanley
Journal:  Glycoconj J       Date:  2012-04-04       Impact factor: 2.916

3.  Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior.

Authors:  Florence Lefranc; Véronique Mathieu; Robert Kiss
Journal:  World J Biol Chem       Date:  2011-09-26

4.  Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1.

Authors:  Aleksandr Kirov; Huda Al-Hashimi; Phil Solomon; Courtney Mazur; Philip E Thorpe; Peter J Sims; Francesca Tarantini; Thallapuranam K Suresh Kumar; Igor Prudovsky
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

5.  Lefty Glycoproteins in Human Embryonic Stem Cells: Extracellular Delivery Route and Posttranslational Modification in Differentiation.

Authors:  Zhila Khalkhali-Ellis; Vasiliy Galat; Yekaterina Galat; Alina Gilgur; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Stem Cells Dev       Date:  2016-09-19       Impact factor: 3.272

6.  Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis.

Authors:  Alice Banh; Jing Zhang; Hongbin Cao; Donna M Bouley; Shirley Kwok; Christina Kong; Amato J Giaccia; Albert C Koong; Quynh-Thu Le
Journal:  Cancer Res       Date:  2011-05-05       Impact factor: 12.701

7.  Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation.

Authors:  Ravi Manjithaya; Christophe Anjard; William F Loomis; Suresh Subramani
Journal:  J Cell Biol       Date:  2010-02-15       Impact factor: 10.539

8.  Unconventional secretion of Acb1 is mediated by autophagosomes.

Authors:  Juan M Duran; Christophe Anjard; Chris Stefan; William F Loomis; Vivek Malhotra
Journal:  J Cell Biol       Date:  2010-02-15       Impact factor: 10.539

9.  Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion.

Authors:  Todd M Greco; Steven H Seeholzer; Adrian Mak; Lynn Spruce; Harry Ischiropoulos
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

10.  Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.

Authors:  Hazuki E Miwa; Wade R Koba; Eugene J Fine; Orsi Giricz; Paraic A Kenny; Pamela Stanley
Journal:  Glycobiology       Date:  2013-09-13       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.